Title of article
Baseline characteristics of participants in the Raloxifene Use for The Heart (RUTH) trial
Author/Authors
Wenger، نويسنده , , Nanette Kass and Barrett-Connor، نويسنده , , Elizabeth C. Collins، نويسنده , , Peter and Grady، نويسنده , , Deborah and Kornitzer، نويسنده , , Marcel and Mosca، نويسنده , , Lori and Sashegyi، نويسنده , , Andreas and Baygani، نويسنده , , Simin K and Anderson، نويسنده , , Pamela W and Moscarelli، نويسنده , , Elena، نويسنده ,
Issue Information
روزنامه با شماره پیاپی سال 2002
Pages
7
From page
1204
To page
1210
Abstract
The Raloxifene Use for The Heart (RUTH) trial is a randomized, placebo-controlled, double-blind trial designed to determine whether raloxifene 60 mg/day compared with placebo lowers the risk of coronary events (coronary death, nonfatal myocardial infarcti
Journal title
American Journal of Cardiology
Serial Year
2002
Journal title
American Journal of Cardiology
Record number
1894915
Link To Document